Oftagel eye gel 2.5mg/g 10g №1

Name:
Ophtagel. Release formGel. INN Carbomer. FTGKeratoprotector.
Description:
Colorless or slightly opalescent gel. Composition Per 1 g Active substance: Carbomer 974R 2.5 mg. Excipients: benzalkonium chloride, sorbitol, lysine monohydrate, sodium acetate, polyvinyl alcohol, water for injection. Pharmacological group Other ophthalmic agents. Artificial tears and other indifferent preparations. ATX code: S01XA20. Pharmacological properties Pharmacodynamics The most important properties of eye drops designed to relieve the symptoms of dry eye are the long contact time of the tear film with the cornea and good moisturizing properties. For this, Oftagel® ophthalmic gel contains carbomer. Carbomer is a high molecular weight carboxyvinyl polymer that increases tear viscosity and is commonly used in eye drops designed to treat dry eyes. These drops form a protective and moisturizing film on the surface of the cornea. Pharmacokinetics The beneficial effect of carbomer in relation to the lengthening of the contact time was found in a clinical trial, phase I. The contact time on the cornea ranged from 12.5 to 45 minutes. Due to the high molecular weight and cross-linked structure of the carbomer, it is unlikely that it will be able to enter or accumulate in the eye. None of the studies revealed reactions caused by this drug, while good local and systemic tolerance was noted. Indications for use Dry keratoconjunctivitis and other diseases accompanied by the “dry eye” syndrome. Contraindications Hypersensitivity to one of the components of the drug. Pregnancy and lactation There have been no adequate controlled trials of the drug in pregnant women. The use of the drug during pregnancy and lactation is only prescribed by a doctor. Method of application and doses 1 drop of Oftagel® 1-4 times a day, depending on the severity of symptoms. Wash your hands before instilling the drug. Tilt your head back. Pull back the lower eyelid and instill one drop of gel into the conjunctival sac between the lower eyelid and the eye. Do not touch the eye or eyelid with the tip of the pipette. Close the vial. Please remember that the ophthalmic gel bottle is for single use only. Ophtagel® eye gel contains benzalkonium chloride as a preservative, which can be deposited on contact lenses. Contact lenses must be removed prior to instillation and reinserted at least 30 minutes after instillation. Overdose No cases of drug overdose have been reported. Side effectImmediately after instillation, transient blurred vision, a short-term burning sensation and local eye irritation are possible. Interaction with other drugs Drug interaction of Oftagel® with other drugs has not been studied. Benzalkonium chloride may be absorbed and discolor contact lenses. Before instillation of the drug, they should be removed and installed again 30 minutes after instillation of the drug. When prescribing more than one type of drops, Oftagel® should be instilled last, with an interval of at least 15 minutes. Effects on professional activityOftagel® ophthalmic gel may cause temporary blurred vision. Before driving a car or working with mechanical devices, you should wait until visual acuity is fully restored. Release formGel ophthalmic 2.5 mg/g. 10 g in a transparent bottle with a capacity of 10 ml, made of low density polyethylene. The bottle is sealed with a pipette, with a screw cap and a ring to control the opening of the bottle. The bottle with instructions is placed in a cardboard box. Storage conditions In a place protected from light, at a temperature of 15 to 25 ° C. Between instillations, the bottle should be stored upside down in a cardboard box to facilitate the flow of the gel. Keep out of the reach of children. Shelf life 30 months. Use within 1 month after opening the vial. Do not use the drug after the expiration date indicated on the package. Terms of dispensing from pharmaciesWithout a prescription. Buy Oftagel ophthalmic gel 2.5mg/g 10g №1